Amdocs (DOX)
(Real Time Quote from BATS)
$86.40 USD
+0.19 (0.22%)
Updated Sep 23, 2024 02:38 PM ET
4-Sell of 5 4
B Value D Growth A Momentum B VGM
Income Statements
Fiscal Year end for Amdocs Limited falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 4,888 | 4,577 | 4,289 | 4,169 | 4,087 |
Cost Of Goods | 3,160 | 2,958 | 2,811 | 2,756 | 2,653 |
Gross Profit | 1,728 | 1,619 | 1,478 | 1,413 | 1,434 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,074 | 954 | 879 | 819 | 864 |
Income After Depreciation & Amortization | 654 | 665 | 599 | 595 | 570 |
Non-Operating Income | 0 | 10 | 226 | 0 | 0 |
Interest Expense | 18 | 26 | 11 | 11 | 2 |
Pretax Income | 636 | 648 | 814 | 583 | 568 |
Income Taxes | 93 | 99 | 126 | 85 | 88 |
Minority Interest | 2 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 543 | 550 | 688 | 498 | 479 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 541 | 550 | 688 | 498 | 479 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 850 | 890 | 808 | 793 | 776 |
Depreciation & Amortization (Cash Flow) | 196 | 225 | 209 | 199 | 206 |
Income After Depreciation & Amortization | 654 | 665 | 599 | 595 | 570 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 120.52 | 123.65 | 129.28 | 134.23 | 138.11 |
Diluted EPS Before Non-Recurring Items | 5.32 | 4.83 | 4.39 | 4.19 | 4.07 |
Diluted Net EPS (GAAP) | 4.49 | 4.44 | 5.32 | 3.71 | 3.47 |
Fiscal Year end for Amdocs Limited falls in the month of September.
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,250.06 | 1,245.85 | 1,245.20 | 1,242.56 | 1,235.96 |
Cost Of Goods | 809.97 | 802.00 | 812.74 | 803.60 | 804.01 |
Gross Profit | 440.09 | 443.85 | 432.46 | 438.96 | 431.96 |
SG&A, R&D, and Dept/Amort Expenses | 264.22 | 288.12 | 248.12 | 300.04 | 249.24 |
Income After SG&A, R&D, and Dept/Amort Expenses | 175.87 | 155.73 | 184.34 | 138.92 | 182.72 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 6.87 | 11.65 | 9.78 | 5.31 | 4.42 |
Pretax Income | 169.00 | 144.08 | 174.56 | 133.62 | 178.29 |
Income Taxes | 28.00 | 24.66 | 25.83 | 30.95 | 18.18 |
Minority Interest | 0.71 | 0.92 | 0.76 | 0.66 | 0.69 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 141.00 | 119.43 | 148.72 | 102.67 | 160.12 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 140.29 | 118.50 | 147.97 | 102.01 | 159.43 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 115.55 | 117.13 | 117.54 | 118.88 | 120.35 |
Diluted EPS Before Non-Recurring Items | 1.44 | 1.38 | 1.38 | 1.25 | 1.41 |
Diluted Net EPS (GAAP) | 1.21 | 1.01 | 1.26 | 0.87 | 1.32 |